论文部分内容阅读
目的本次实验将对比克拉霉素(口服)、红霉素(静滴)对小儿呼吸道支原体感染的疗效。方法本次实验选取了2016年6月~2016年12月在我院就诊的130例小儿呼吸道支原体感染患儿,采用数字随机法分为对照组和观察组,对照组采用静滴红霉素的方式治疗,观察组则采用口服克拉霉素的方式治疗。结果观察组治疗总有效率为89.23%,对照组则为70.77%,两组差异显著,具有统计学意义(P<0.05)。结论针对小儿呼吸道支原体感染采用口服克拉霉素的治疗更为有效性,安全性高,值得在临床过程中推广应用。
Objectives This experiment will compare the efficacy of clarithromycin (oral), erythromycin (intravenous) on children with respiratory tract mycoplasma infection. Methods A total of 130 children with respiratory tract mycoplasma infection were selected from June 2016 to December 2016 in our hospital. The patients were divided into control group and observation group by digital random method. The control group was treated with erythromycin Way of treatment, the observation group was treated with oral clarithromycin. Results The total effective rate was 89.23% in the observation group and 70.77% in the control group, with significant difference between the two groups (P <0.05). Conclusion The treatment of children with respiratory tract mycoplasma infection oral clarithromycin more effective, safe, it is worth in the clinical application.